LPA<sub>3</sub>: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites
<b>Background:</b> Lysophosphatidic acid (LPA) receptor 3 (LPA<sub>3</sub>) is involved in many physiological and pathophysiological actions of this bioactive lipid, particularly in cancer. The actions of LPA and oleoyl-methoxy glycerophosphothionate (OMPT) were compared in L...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Receptors |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2813-2564/3/4/29 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850036153536741376 |
|---|---|
| author | K. Helivier Solís M. Teresa Romero-Ávila Ruth Rincón-Heredia Juan Carlos Martínez-Morales J. Adolfo García-Sáinz |
| author_facet | K. Helivier Solís M. Teresa Romero-Ávila Ruth Rincón-Heredia Juan Carlos Martínez-Morales J. Adolfo García-Sáinz |
| author_sort | K. Helivier Solís |
| collection | DOAJ |
| description | <b>Background:</b> Lysophosphatidic acid (LPA) receptor 3 (LPA<sub>3</sub>) is involved in many physiological and pathophysiological actions of this bioactive lipid, particularly in cancer. The actions of LPA and oleoyl-methoxy glycerophosphothionate (OMPT) were compared in LPA<sub>3</sub>-transfected HEK 293 cells. <b>Methods</b>: Receptor phosphorylation, ERK 1/2 activation, LPA<sub>3</sub>-β-arrestin 2 interaction, and changes in intracellular calcium were analyzed. <b>Results</b>: Our data indicate that LPA and OMPT increased LPA<sub>3</sub> phosphorylation, OMPT being considerably more potent than LPA. OMPT was also more potent than LPA to activate ERK 1/2. In contrast, OMPT was less effective in increasing intracellular calcium than LPA. The LPA-induced LPA<sub>3</sub>-β-arrestin 2 interaction was fast and robust, whereas that induced by OMPT was only detected at 60 min of incubation. LPA- and OMPT-induced receptor internalization was fast, but that induced by OMPT was more marked. LPA-induced internalization was blocked by Pitstop 2, whereas OMPT-induced receptor internalization was partially inhibited by Pitstop 2 and Filipin and entirely by the combination of both. When LPA-stimulated cells were rechallenged with 1 µM LPA, hardly any response was detected, i.e., a “refractory” state was induced. However, a conspicuous and robust response was observed if OMPT was used as the second stimulus. <b>Conclusions:</b> The differences in these agents’ actions suggest that OMPT is a biased agonist. These findings suggest that two binding sites for these agonists might exist in the LPA<sub>3</sub> receptor, one showing a very high affinity for OMPT and another likely shared by LPA and OMPT (structural analogs) with lower affinity. |
| format | Article |
| id | doaj-art-58dc5a4f7b0f49248c046154d41c2074 |
| institution | DOAJ |
| issn | 2813-2564 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Receptors |
| spelling | doaj-art-58dc5a4f7b0f49248c046154d41c20742025-08-20T02:57:17ZengMDPI AGReceptors2813-25642024-12-013455557310.3390/receptors3040029LPA<sub>3</sub>: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two SitesK. Helivier Solís0M. Teresa Romero-Ávila1Ruth Rincón-Heredia2Juan Carlos Martínez-Morales3J. Adolfo García-Sáinz4Departamento de Biología Celular y Desarrollo, Ciudad de México 04510, MexicoDepartamento de Biología Celular y Desarrollo, Ciudad de México 04510, MexicoUnidad de Imagenología, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ap. Postal 70-600, Ciudad de México 04510, MexicoDepartamento de Biología Celular y Desarrollo, Ciudad de México 04510, MexicoDepartamento de Biología Celular y Desarrollo, Ciudad de México 04510, Mexico<b>Background:</b> Lysophosphatidic acid (LPA) receptor 3 (LPA<sub>3</sub>) is involved in many physiological and pathophysiological actions of this bioactive lipid, particularly in cancer. The actions of LPA and oleoyl-methoxy glycerophosphothionate (OMPT) were compared in LPA<sub>3</sub>-transfected HEK 293 cells. <b>Methods</b>: Receptor phosphorylation, ERK 1/2 activation, LPA<sub>3</sub>-β-arrestin 2 interaction, and changes in intracellular calcium were analyzed. <b>Results</b>: Our data indicate that LPA and OMPT increased LPA<sub>3</sub> phosphorylation, OMPT being considerably more potent than LPA. OMPT was also more potent than LPA to activate ERK 1/2. In contrast, OMPT was less effective in increasing intracellular calcium than LPA. The LPA-induced LPA<sub>3</sub>-β-arrestin 2 interaction was fast and robust, whereas that induced by OMPT was only detected at 60 min of incubation. LPA- and OMPT-induced receptor internalization was fast, but that induced by OMPT was more marked. LPA-induced internalization was blocked by Pitstop 2, whereas OMPT-induced receptor internalization was partially inhibited by Pitstop 2 and Filipin and entirely by the combination of both. When LPA-stimulated cells were rechallenged with 1 µM LPA, hardly any response was detected, i.e., a “refractory” state was induced. However, a conspicuous and robust response was observed if OMPT was used as the second stimulus. <b>Conclusions:</b> The differences in these agents’ actions suggest that OMPT is a biased agonist. These findings suggest that two binding sites for these agonists might exist in the LPA<sub>3</sub> receptor, one showing a very high affinity for OMPT and another likely shared by LPA and OMPT (structural analogs) with lower affinity.https://www.mdpi.com/2813-2564/3/4/29lysophosphatidic acidLPALPA<sub>3</sub> receptoroleoyl-methoxy glycerophosphothionateOMPTbiased agonism |
| spellingShingle | K. Helivier Solís M. Teresa Romero-Ávila Ruth Rincón-Heredia Juan Carlos Martínez-Morales J. Adolfo García-Sáinz LPA<sub>3</sub>: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites Receptors lysophosphatidic acid LPA LPA<sub>3</sub> receptor oleoyl-methoxy glycerophosphothionate OMPT biased agonism |
| title | LPA<sub>3</sub>: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites |
| title_full | LPA<sub>3</sub>: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites |
| title_fullStr | LPA<sub>3</sub>: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites |
| title_full_unstemmed | LPA<sub>3</sub>: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites |
| title_short | LPA<sub>3</sub>: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites |
| title_sort | lpa sub 3 sub pharmacodynamic differences between lysophosphatidic acid and oleoyl methoxy glycerophosphothionate biased agonism two sites |
| topic | lysophosphatidic acid LPA LPA<sub>3</sub> receptor oleoyl-methoxy glycerophosphothionate OMPT biased agonism |
| url | https://www.mdpi.com/2813-2564/3/4/29 |
| work_keys_str_mv | AT kheliviersolis lpasub3subpharmacodynamicdifferencesbetweenlysophosphatidicacidandoleoylmethoxyglycerophosphothionatebiasedagonismtwosites AT mteresaromeroavila lpasub3subpharmacodynamicdifferencesbetweenlysophosphatidicacidandoleoylmethoxyglycerophosphothionatebiasedagonismtwosites AT ruthrinconheredia lpasub3subpharmacodynamicdifferencesbetweenlysophosphatidicacidandoleoylmethoxyglycerophosphothionatebiasedagonismtwosites AT juancarlosmartinezmorales lpasub3subpharmacodynamicdifferencesbetweenlysophosphatidicacidandoleoylmethoxyglycerophosphothionatebiasedagonismtwosites AT jadolfogarciasainz lpasub3subpharmacodynamicdifferencesbetweenlysophosphatidicacidandoleoylmethoxyglycerophosphothionatebiasedagonismtwosites |